藥物發現資訊學市場－全球產業規模、佔有率、趨勢、機會和預測，依模式、工作流程、服務、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球藥物發現資訊學市場規模為34.8億美元，預計2030年將以9.40%的複合年成長率成長至59.7億美元。藥物發現資訊學是指應用計算方法和分析工具來管理、分析和解讀藥物發現過程中產生的大量且多樣化的資料，從而提高識別和最佳化潛在候選藥物的效率。該市場的成長主要受以下因素驅動：對藥物研發的大量投資、處理日益成長且複雜的科學資料的必要性，以及縮短藥物研發週期和降低相關成本的持續壓力。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球藥物發現資訊學市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按模式（內部開發、外包）
  • 按工作流程（探索、開發）
  • 依服務分類（序列分析平台、分子建模、分子對接、臨床試驗資料管理、其他）
  • 按最終用戶（製藥和生物技術公司、合約研究組織 (CRO)、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美藥物發現資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲藥物發現資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區藥物發現資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲藥物發現資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美藥物發現資訊學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球藥物發現資訊學市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Dassault Systemes SE
• IBM Corporation
• Infosys Ltd.
• Schrodinger Inc.
• Jubilant Life Sciences NV
• Aragen Lifescience Ltd.
• Charles River Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Clarivate Analytics LLC
• PerkinElmer Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Drug Discovery Informatics Market, valued at USD 3.48 Billion in 2024, is projected to experience a CAGR of 9.40% to reach USD 5.97 Billion by 2030. Drug discovery informatics involves the application of computational methods and analytical tools to manage, analyze, and interpret the extensive and varied data generated throughout the drug discovery process, thereby enhancing the efficiency of identifying and optimizing potential drug candidates. The market's growth is primarily driven by substantial investments in pharmaceutical research and development, a necessity to process the increasing volume and complexity of scientific data, and the continuous pressure to reduce drug development timelines and associated costs.

Key Market Drivers

The rapid proliferation of big data in drug discovery is a core driver accelerating the growth of the informatics market. The escalating volume and complexity of data generated from genomic sequencing, proteomics, and advanced experimental assays require sophisticated computational tools for effective data management, analysis, and interpretation. This expanding data ecosystem is driving strong demand for informatics platforms capable of integrating diverse datasets and transforming them into actionable insights for identifying and prioritising potential drug candidates. Reflecting the scale of this data generation, the report Genomics Market Size, Trends and Tailored Solutions for Personalized Medicine stated that the global genomics market was valued at USD 38.52 billion in 2024, underscoring the magnitude of information being produced and the corresponding need for high-performance informatics solutions to accelerate early-stage drug development.

Key Market Challenges

The complexity of data integration and persistent interoperability challenges across fragmented platforms and heterogeneous data sources pose a significant constraint on the growth of the Global Drug Discovery Informatics Market. The pharmaceutical industry produces vast volumes of diverse data across multiple workflows, including genomics, proteomics, and clinical trials. However, these datasets frequently remain siloed within disconnected systems, creating substantial barriers to standardisation, consolidation, and holistic analysis. This lack of seamless integration limits the ability to establish a unified and comprehensive research view, which is essential for accelerating drug candidate identification and optimisation.

Key Market Trends

The adoption of cloud-native informatics platforms represents a significant trend in the global drug discovery informatics market, moving away from on-premise infrastructure to scalable, accessible cloud-based solutions. This shift provides enhanced flexibility and computational power for managing and analyzing the vast datasets generated in drug discovery. According to a Pistoia Alliance survey published in September 2025, 80% of life sciences labs now utilize cloud data platforms, marking an increase from 70% in 2023. This growth underscores the industry's recognition of cloud benefits, including improved collaboration and reduced IT overheads.

Key Market Players

• Dassault Systemes SE
• IBM Corporation
• Infosys Ltd.
• Schrodinger Inc.
• Jubilant Life Sciences NV
• Aragen Lifescience Ltd.
• Charles River Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Clarivate Analytics LLC
• PerkinElmer Inc.

Report Scope:

In this report, the Global Drug Discovery Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Discovery Informatics Market, By Mode:

• In-house
• Outsourced

Drug Discovery Informatics Market, By Workflow:

• Discovery
• Development

Drug Discovery Informatics Market, By Services:

• Sequence Analysis Platforms
• Molecular Modelling
• Docking
• Clinical Trial Data Management
• Others

Drug Discovery Informatics Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROS)
• Others

Drug Discovery Informatics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Drug Discovery Informatics Market.

Available Customizations:

Global Drug Discovery Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Drug Discovery Informatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Mode (In-house, Outsourced)
  • 5.2.2. By Workflow (Discovery, Development)
  • 5.2.3. By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others)
  • 5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Drug Discovery Informatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Mode
  • 6.2.2. By Workflow
  • 6.2.3. By Services
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Drug Discovery Informatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Mode
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By Services
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Drug Discovery Informatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Mode
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By Services
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Drug Discovery Informatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Mode
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By Services
      • 6.3.3.2.4. By End User

7. Europe Drug Discovery Informatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Mode
  • 7.2.2. By Workflow
  • 7.2.3. By Services
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Drug Discovery Informatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Mode
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By Services
      • 7.3.1.2.4. By End User
  • 7.3.2. France Drug Discovery Informatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Mode
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By Services
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Drug Discovery Informatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Mode
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By Services
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Drug Discovery Informatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Mode
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By Services
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Drug Discovery Informatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Mode
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By Services
      • 7.3.5.2.4. By End User

8. Asia Pacific Drug Discovery Informatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Mode
  • 8.2.2. By Workflow
  • 8.2.3. By Services
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Drug Discovery Informatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Mode
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By Services
      • 8.3.1.2.4. By End User
  • 8.3.2. India Drug Discovery Informatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Mode
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By Services
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Drug Discovery Informatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Mode
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By Services
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Drug Discovery Informatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Mode
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By Services
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Drug Discovery Informatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Mode
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By Services
      • 8.3.5.2.4. By End User

9. Middle East & Africa Drug Discovery Informatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Mode
  • 9.2.2. By Workflow
  • 9.2.3. By Services
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Drug Discovery Informatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Mode
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By Services
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Drug Discovery Informatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Mode
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By Services
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Drug Discovery Informatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Mode
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By Services
      • 9.3.3.2.4. By End User

10. South America Drug Discovery Informatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Mode
  • 10.2.2. By Workflow
  • 10.2.3. By Services
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Drug Discovery Informatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Mode
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By Services
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Drug Discovery Informatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Mode
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By Services
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Drug Discovery Informatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Mode
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By Services
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Drug Discovery Informatics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dassault Systemes SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. IBM Corporation
• 15.3. Infosys Ltd.
• 15.4. Schrodinger Inc.
• 15.5. Jubilant Life Sciences NV
• 15.6. Aragen Lifescience Ltd.
• 15.7. Charles River Laboratories Inc.
• 15.8. Thermo Fisher Scientific Inc.
• 15.9. Clarivate Analytics LLC
• 15.10. PerkinElmer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer